Cann Group
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
Cann Group earns an Underweight rating, with a composite score near 30 and conviction at one out of five. The regulatory pillar leads at 56, supported by Australia’s jurisdiction posture score of 72 and an enforcement subscore of 80. That relative strength fails to offset a fundamentals pillar of 23, where operating profitability, market-cap tier, and cash runway score poorly. The market pillar contributes only 15 because recorded trading volume is nil, while the editorial pillar reaches 30 despite no newsroom or brief activity. The resulting profile combines limited market validation, weak operating economics, and stretched financial condition.
Licensed fundamentals data show year-over-year revenue contraction of roughly 30%, sharply reducing the basis for operating leverage. Gross margin remains comparatively constructive at approximately 46%, reflected in a gross-margin subscore of 76, but the operating margin stands near negative 133% and EBITDA is negative by about $7.2 million. Reported net income of roughly $14.7 million does not alter the stretched assessment given the EBITDA loss, a cash-burn ratio above one, and a cash-runway subscore of 15. Market capitalization is approximately $6.6 million, consistent with a zero market-cap-tier subscore. Primary regulatory filings show no recorded events across either the 90-day or 180-day windows, no enforcement hits, and no available latest-filing date; accordingly, filing cadence scores only 25. Institutional pricing feeds and CIN newsroom coverage add no stronger offset, with zero volume and no coverage hits.
The clearest rerating catalyst sits within the regulatory pillar, already the strongest component of the scorecard. Australia’s favorable jurisdiction posture and the absence of enforcement hits provide a platform for improvement, but the low cadence score prevents that platform from carrying greater weight. More regular primary regulatory filings could raise transparency, document operational progress, and strengthen confidence in reported financial trends without relying on thin trading activity or sparse editorial attention. Such progress would also create a firmer bridge between the 46% gross margin and any eventual narrowing of the deeply negative operating margin. The single most important signal to watch is the appearance of a current primary regulatory filing that establishes a consistent reporting cadence.
- IR / PR agency
- NWR Communications
- IR email
- contact@canngrouplimited.com
- IR page
- Investor relations
- Headquarters
- 28 AYER RAJAH CRESCENT, #06-08, SINGAPORE, U0, 139959
- Phone
- 65 6305 6618
- CEO
- Mike Ryan (Interim Executive Chairman)
- CFO
- David Hine
- Auditor
- KPMG Huazhen LLP
- SEC CIK
- 1780652
- Website
- Company website
- Market cap
- $6.6M
- Enterprise value
- $20.6M
- P/E ratio
- 0.4
- Price to book
- 0.22
- Price to sales
- 0.66
- EV / EBITDA
- 0.73
- Revenue (TTM)
- $11.3M
- Gross profit (TTM)
- $5.2M
- EBITDA
- $-7.2M
- Operating margin
- -132.8%
- Profit margin
- 130.3%
- Rev growth YoY
- -30.1%
- Return on equity
- 72.6%
- Return on assets
- -13.0%
- EPS (TTM)
- $0.01
- Wall St. target price
- $5.00
- Shares outstanding
- 1,660.6M
- Insider ownership
- 22.0%
- Institutional ownership
- 3.6%
- Beta
- 0.11
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Annual report
- Latest 10-K
- Filing portal
- ASX Announcements
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Cann Group (CAN)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Cann Group (CAN), a cannabis-sector equity listed on ASX. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
Analyst average price target $1.57.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, micro-cap. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for CAN are maintained by Cannabis Investor News and refreshed throughout the trading day.